X-linked myoclonic epilepsy with spasticity and intellectual disability
Mutation in the homeobox gene ARX
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To describe a new syndrome of X-linked myoclonic epilepsy with generalized spasticity and intellectual disability (XMESID) and identify the gene defect underlying this disorder.
Methods: The authors studied a family in which six boys over two generations had intractable seizures using a validated seizure questionnaire, clinical examination, and EEG studies. Previous records and investigations were obtained. Information on seizure disorders was obtained on 271 members of the extended family. Molecular genetic analysis included linkage studies and mutational analysis using a positional candidate gene approach.
Results: All six affected boys had myoclonic seizures and TCS; two had infantile spasms, but only one had hypsarrhythmia. EEG studies show diffuse background slowing with slow generalized spike wave activity. All affected boys had moderate to profound intellectual disability. Hyperreflexia was observed in obligate carrier women. A late-onset progressive spastic ataxia in the matriarch raises the possibility of late clinical manifestations in obligate carriers. The disorder was mapped to Xp11.2–22.2 with a maximum lod score of 1.8. As recently reported, a missense mutation (1058C>T/P353L) was identified within the homeodomain of the novel human Aristaless related homeobox gene (ARX).
Conclusions: XMESID is a rare X-linked recessive myoclonic epilepsy with spasticity and intellectual disability in boys. Hyperreflexia is found in carrier women. XMESID is associated with a missense mutation in ARX. This disorder is allelic with X-linked infantile spasms (ISSX; MIM 308350) where polyalanine tract expansions are the commonly observed molecular defect. Mutations of ARX are associated with a wide range of phenotypes; functional studies in the future may lend insights to the neurobiology of myoclonic seizures and infantile spasms.
Intellectual disability occurs more frequently in boys than in girls. Many X-linked mental retardation syndromes have been mapped and genes identified.1 Although epilepsy may be present, it is seldom a key feature of these syndromes. For example in fragile X syndrome, seizures occur in 18% of cases.2 One condition where seizures are a central feature is the rare syndrome of X-linked infantile spasms (ISSX; MIM 308350).3
Here we describe a family with the unique combination of X-linked myoclonic epilepsy, intellectual disability, and generalized spasticity. Obligate carrier women are normal apart from hyperreflexia. The elderly matriarch has a late onset progressive neurologic disorder and we raise the question of whether this could be a late manifestation of the same genetic defect.
The novel human Aristaless related homeobox gene (ARX) was recently identified as the causative gene in ISSX, and in some families with X-linked syndromic and nonsyndromic mental retardation, including patients with dystonia.4 A missense mutation in ARX was also reported in the family detailed here.4 The complex phenotype that we observed in this family shows significant differences in seizure and neurologic manifestations compared to ISSX. This presumably reflects the different nature and location of the molecular defect because this family had the only missense mutation confined to the homeodomain of ARX gene.
Methods.
Ascertainment and genealogic documentation.
The Australian family was referred from Western Victoria because epilepsy and intellectual disability were noted in the boys. A detailed pedigree of the family was constructed extending as far back as possible along both maternal and paternal lines.
Clinical evaluation.
Initial clinical information was obtained from family members by a systematized telephone interview. A history of seizures was sought on all family members using a validated seizure questionnaire.5 Where a history of seizures was obtained, the clinical description was corroborated by questioning relatives for eyewitness accounts where possible. Previous investigations were obtained from medical records and treating doctors, including EEG and neuroimaging studies such as MRI and CT brain studies. All living individuals in the main part of the pedigree (II-8 and her descendants) were personally examined.
Classification of epilepsies.
The seizure types were classified according to the International Classification of Epileptic Seizures6 and the epilepsy phenotypes according to the International Classification of Epilepsies and Epileptic Syndromes.7
Venous blood for molecular genetic studies was taken from all available family members in the main part of the kindred. The study was approved by the Human Research Ethics Committee of the Austin & Repatriation Medical Center. Informed consent was obtained from all participating individuals and parents/guardians in the case of minors.
Genetic analysis.
Linkage studies to the X chromosome were performed to map the critical region of the X chromosome to identify a disease locus. Automated genotyping of microsatellite markers spread along the X chromosome was carried out at the Australian Genome Research Facility, Melbourne. Genotypes were analyzed by MLINK to establish a gene localization by linkage assuming X-linked recessive inheritance, a disease allele frequency of 0.0001, 100% penetrance and equal marker allele frequencies. Using these parameters and assuming linkage to a marker with four alleles, the theoretical maximum lod score was calculated using SLINK.
Once localized, the interval was refined by manually genotyping additional markers from the region. A search for suitable candidate genes was carried out in the mapped region.
Candidate gene selection.
Prior to the identification of the ARX gene,4 five other positional candidate genes were screened for mutations in this family. These include STK9 (a serine-threonine kinase 9) AOE372 (a thioredoxin peroxidase),PCYT1B (a choline esterase), ILIRAPL1 (interleukin receptor accessory protein like 1), and a yet uncharacterized gene Hs.40065. Candidate genes were selected from the minimal overlapping interval of linkage localization in this family (see above) and two families with ISSX.8,9⇓ All five candidate genes were screened using direct dideoxy fluorescent cycle sequencing of PCR products of individual exons amplified from genomic DNA of an affected boy. Primer sequences and PCR conditions are available upon request (from J. Gecz at jozef.gecz@adelaide.edu.au).
Results.
The Australian family was nonconsanguineous and is shown in figure 1. Information was obtained on 271 family members, and 11 individuals had a history of seizures. The family originally derived from the United Kingdom.
Figure 1. Pedigree of the family. ▪ = X-linked myoclonic epilepsy with spasticity and intellectual disability (XMESID); = adult onset progressive spastic ataxia; = epilepsy; = febrile seizures; = learning difficulties; = obligate carrier; ↖ = proband; ★ = family history of epilepsy. X chromosome haplotypes are boxed according to the markers listed.
In the main part of the family (II-7, II-8 and their descendants), there were six affected boys and three obligate carrier women. Four living affected boys were personally assessed; two were deceased. All living affected boys had intractable epilepsy, intellectual disability, and spasticity.
Case histories.
Proband IV-47.
The proband was a 5-year-old boy who developed seizures at age 10 months, characterized by extension of his upper limbs above his head and jerking backwards. Both infantile spasms and tonic seizures were recorded on video-EEG studies. Interictal EEG showed multifocal epileptiform activity localized predominantly to the left temporal region, but also seen on the right. The infantile spasms were associated with high amplitude generalized polyphasic sharp waves and spikes with left hemisphere predominance; typical hypsarrhythmia was not seen. During a generalized tonic seizure, bilateral upper limb extension was accompanied by 2 Hz rhythmic discharges slowing to 1 Hz polyphasic spike and slow wave activity. The tonic seizure lasted 45 seconds and in the second half of the seizure, the head and eyes deviated to the left. By age 5, seizures occurred twice per day, typically in sleep and began with a scream. They involved generalized stiffening with some jerking toward the end of the seizure; it was unclear if they were all tonic seizures or if some were tonic-clonic seizures (TCS). There was often a series of myoclonic jerks at the end of the major seizure. He had daily atonic head nods with upper limb myoclonic jerks lasting 1 second with postictal irritability. He did not have febrile convulsions nor convulsive status epilepticus. He took 140 mg of carbamazepine three times daily, and had previously tried sodium valproate and clonazepam.
The pregnancy and perinatal history were unremarkable. He was able to fix and follow by 6 weeks. He smiled late but was affectionate. He acquired two single words at age 41/2, but was not able to follow a single command. At age 5, he had severe global developmental delay; he could sit but not pull to stand nor walk. He was ambidextrous and had a primitive grasp. Developmental regression had not occurred.
On examination, he had a moderately severe asymmetric spastic quadriparesis with hypertonia and hyperreflexia, more pronounced on the right. Plantar responses were down-going. He had a convergent strabismus. Head circumference was 51 cm (50th percentile) and weight was 18 kg (25th percentile). There were no dysmorphic features nor neurocutaneous stigmata and general examination was normal.
His EEG at age 5 showed continuous slow 2 Hz generalized spike wave activity awake and asleep (figure 2). MRI brain scan at 23 months showed questionable cerebral atrophy with normal myelination. There was cavum septum vergae but no dysplasia. Muscle biopsy at age 23/4 showed a mild increase in lipid but no evidence of a mitochondrial cytopathy. Other normal investigations included karyotype, CSF and blood lactate, very long chain fatty acids, phytanic acid, fragile X DNA studies, the common mutations for MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes), MERRF (myoclonic epilepsy associated with ragged-red fibers), NARP (neuropathy, ataxia, and retinitis pigmentosa), Leigh syndrome, respiratory chain enzymes in skeletal muscle, urine amino acids, and CT brain scan with contrast.
Figure 2. EEG of the proband IV-47. The awake EEG shows continuous slow generalized spike wave activity with a bifrontal predominance.
Individual IV-46.
The most mildly affected boy was a 10-year-old whose absence seizures began at 18 months. These consisted of 2- to 3-second staring episodes that improved with the introduction of sodium valproate. TCS without aura began at age 9, and he had a total of three 30- to 60-second convulsions, two triggered by looking at lights. Myoclonic seizures occurred in the mornings and also toward the end of an absence seizure. He had not had febrile seizures nor drop attacks.
The pregnancy and perinatal history were unremarkable. Concerns about his developmental progress arose at 6 months. By age 2, he could crawl but not walk. A cystoperitoneal shunt was inserted at 24 months for decompression of a posterior fossa cyst with subsequent improvement in balance; he walked at 32 months. He underwent strabismus repair at age 6. By age 10, he spoke two- or three-word phrases, could follow a series of three commands, ran awkwardly, and scribbled lines. His eye contact was variable, and he was not continent. He had never regressed.
Examination revealed mild generalized spasticity with mild generalized hypertonia and sustained clonus at the left ankle and down-going plantar responses bilaterally. He had a stooped posture with a spastic gait and was not able to follow instructions. He had a convergent strabismus. There were no neurocutaneous or dysmorphic features. Head circumference was 56 cm (98th centile). His weight was 41 kg (90th percentile).
Routine EEG at age 10 showed mild to moderate diffuse background slowing without epileptiform features. CT brain scan showed a large posterior fossa cyst; the brain and ventricular system appeared normal.
Individual III-38.
This 32-year-old man was the only affected individual with a history of regression. He was the result of a normal pregnancy and forceps delivery at term. By day 1 of age, a cleft palate was noted and he seemed floppier and less alert than normal. Early development was delayed, with sitting at 1 year and walking at age 9. He spoke two single words from age 5, but was unable to follow a simple command. He was ambidextrous, and could finger feed and use a spoon.
He developed TCS at 5 months, with five TCS per day without fever. He also had diurnal myoclonic seizures. At age 19, he had convulsive status epilepticus for at least 60 minutes followed by 48 hours of coma and marked developmental regression. He was no longer able to walk or hold a cup.
On examination, he had generalized myoclonic seizures and was wheelchair bound. He had severe generalized spastic quadriparesis with bilateral up-going plantar responses. Head circumference was 55 cm (30th percentile). He had a kyphosis but no other dysmorphic or neurocutaneous stigmata.
DNA analysis for the most common mutations for the fragile X syndrome (FRAXA) and the FRAXE syndrome (OMIM*309548) were negative. Routine study EEG showed diffuse background slowing with 2 Hz slow generalized spike wave activity.
Individual IV-42.
Individual IV-42 was born by forceps delivery at term in good condition weighing 3 kg. His mother’s pregnancy was complicated by vomiting and dehydration, requiring hospitalization at 3 months. At birth, he was very floppy. Eye examination at 11 months was normal. Developmental progress was extremely slow but regression did not occur. By age 41/2, he could fix and follow and appeared to hear. He could not roll over or sit, nor did he speak, smile, or laugh. He could grasp but not reach.
Brief seizures began at 3 months; at 5 months, afebrile convulsive status epilepticus occurred and phenytoin was commenced. Thereafter, brief TCS occurred a few times per week. He also experienced absence and myoclonic seizures. Video-EEG monitoring at 9 months captured a partial seizure which began with brief tonic features then clonic activity of the left lower limb and waving of the left hand. Truncal extension occurred with head deviation to the right and tremor of the right hand. Bicycling movements of the legs were noted. Toward the latter part of the 3-minute seizure, he was still with head and eye deviation to the right. The EEG correlate of this seizure began with a 5-second generalized electrodecremental response, followed by high amplitude left temporal slow sharp activity evolving to 6 Hz sharp and spike discharges, which gradually evolved to delta activity. Frequent episodes of convulsive status epilepticus occurred and he spent much of his life in hospital. He died at age 41/2 in status epilepticus.
Examination at age 17 months revealed truncal hypotonia and increased peripheral muscle tone with scissoring. Chromosomal analysis and CT brain scan were normal.
Matriarch II-8.
The maternal grandmother of the proband was 61 years old and had a 12-year history of progressive difficulty walking and unsteadiness. She eventually became wheelchair bound because she could only walk a few meters. She had a progressive spastic quadriparesis. Her gait was wide-based and ataxic, suggestive of a superimposed truncal cerebellar component. Plantar responses were down-going. She had a tremor involving her limbs and jaw without appendicular cerebellar signs. She had a past history of a toxic goiter (treated with radioiodine), hypertension, ischemic heart disease, and agoraphobia.
Investigations showed normal mitochondrial DNA analysis for the common mutations in NARP, MELAS, and MERRF; normal myotonic dystrophy DNA and spinocerebellar ataxia type 6 DNA studies, normal thyroid function test, antinuclear antibodies, and vitamin E. Muscle biopsy revealed mild fiber atrophy but no evidence of a mitochondrial cytopathy. MRI of the cervical cord was normal. MRI of the brain showed small foci of T2 hyperintensity in the white matter, consistent with small vessel ischemic changes. Her EEG was normal.
Affected boys.
Epileptology.
Of the six affected boys in the main branch of the family, the mean age of seizure onset was 7 months (range 2 to 18 months) with earlier onset correlating with more severe developmental impairment. Four boys presented with TCS, one (IV-46) presented with absence seizures, and one (IV-47) had infantile spasms and tonic seizures at onset. Infantile spasms were seen in one other affected boy (III-37) at 6 months while undergoing video-EEG monitoring. All boys developed myoclonic seizures and TCS over time, two had tonic seizures, convulsive status occurred in two boys, and absence and atonic seizures were seen in one boy each. Absence seizures could be difficult to discern in the affected boys. Overall, affected boys had hundreds of seizures and were refractory to multiple antiepileptic medications. Two boys died in early childhood, III-37 at 19 months and IV-42 at age 41/2, the latter during a seizure. (Data are presented in table 1.)
Table 1 Clinical data of affected family members
EEG studies were performed in all four living affected boys. All recordings showed mild to moderate diffuse background slowing with generalized spike wave activity in three. The one boy (IV-46) without epileptiform activity was the least severely affected boy. One of the two boys with infantile spasms had typical hypsarrhythmia (III-37), the other did not (see proband IV-47 case history).
Clinical features.
All affected boys had severe global developmental delay. This varied in degree. They were able to sit between ages 1 and 4; only two ever walked independently, IV-46 at 32 months, and III-38 at age 9. Only four acquired single words between 18 months and 5 years, with three gaining 10 single words at most; IV-46 put two or three words together. On history, the two deceased boys were profoundly impaired: IV-42 could grasp but not reach or fix, and III-37 could not fix nor support his head. Only one (III-38) had a history of regression, this followed status epilepticus at age 19. (Data are presented in table 1.)
All affected boys had generalized spasticity, which varied in severity from mild in IV-46, who was able to walk, to severe in the remaining three living boys who were wheelchair bound. There were no neurocutaneous stigmata.
Obligate carrier women.
The family contained three obligate carrier women (II-8, III-34, III-35), and two girls (IV-43, IV-45) who have a 50% chance of being carriers. The obligate carrier women did not have seizures. They had normal early development and were of normal intellect, with the exception of III-34 who had learning difficulties. Neurologic examination revealed subtle, but definite, generalized hyperreflexia with normal tone, power, coordination, and down-going plantar responses. The matriarch of the family (II-8) had a late onset progressive spastic ataxia (see case history).
EEG studies were performed on the three obligate carriers and the two girls at risk of being carriers. These routine studies were normal in four, and individual III-35 had focal slowing over the right hemisphere without epileptiform features.
Extended family.
Five individuals in the wider family had a history of seizures. One child, IV-2, had a history of a single typical febrile seizure at age 2. His brother, IV-1, had febrile seizures followed by later absence seizures. Their mother, III-1, who married into the family, had two febrile seizures at age 2, and her brother had epilepsy. No information was obtained on individual IV-21 because he was unwilling to participate in the study. Individual II-16 was 71 years old and in institutional care. She had been intellectually disabled all her life and had generalized TCS beginning at age 4. More detailed information to characterize her seizure disorder could not be obtained.
Clinical genetic analysis.
The pattern of inheritance of epilepsy, intellectual disability, and spasticity in affected boys is consistent with X-linked recessive inheritance in the main branch of the family. The obligate carrier women had subtle hyperreflexia which may be a marker of carrier status. It is possible that the late-onset spastic ataxia in the matriarch is a late-manifesting feature of the same gene that is responsible for the boys’ severe impairment (see case history II-8). If the matriarch is a late-manifesting carrier of this gene, this could hold further implications for the other obligate carrier women.
The seizure disorders in the extended family were mostly mild and clinically distinct from the syndrome in the main family of a severe myoclonic seizure disorder with spasticity and intellectual disability in boys. Individuals with seizures due to another cause are likely to be ascertained in large kindreds given the prevalence of epilepsy in the general population. Moreover, there were three instances where a bilineal history of seizure disorders was seen in the wider family, suggesting that other genes may play a role.
Molecular genetic analysis.
Mapping studies were consistent with X-linkage with a maximum lod score of 1.8 for several markers (DXS987, DXS1226, DXS1214, DXS1068) within the regional localization defined by DXS7108 and DXS993 (table 2). This comprises an interval of approximately 46 cM. Recombination events excluded a localization to the remainder of the chromosome (see table 2). Simulated linkage analysis using SLINK predicted that the theoretical maximal lod score for this family is about 1.87.
Table 2 Two-point lod scores of markers spanning the entire X chromosome
Five candidate genes were screened negative for mutations in this family: STK9, AOE372, PCYT1B, Hs.40065, and IL1RAPL1. Among these, disease-causing mutations were previously found only in the IL1RAPL1 gene in cases with nonsyndromic mental retardation.10
As part of this positional candidate approach, we have also identified a novel human homeobox gene, Aristaless-related homeobox gene, ARX, from the region. Mutations of the ARX gene were subsequently identified in, among others, four families with ISSX.4 Screening of the ARX gene in the family reported here identified a novel missense mutation at position 1058 of the ARX open reading frame (ORF). This change of nucleotide cytosine (C) 1058 to thymine (T) (1058C>T) is predicted to cause a change of the amino acid proline (P) at the position 353 to leucine (L) in the mature ARX protein. This P353L change is a nonconservative change.
When tested on the pedigree, the 1058C>T change perfectly segregated with the myoclonic epilepsy phenotype observed in this family4 (results not shown). Moreover, this 1058C>T change was not found in more than 100 control chromosomes tested so far.
The 1058C>T or P353L mutation is within the highly conserved homeodomain of the ARX protein. Although proline 353 (often referred to as P26 of the homeodomain) is not directly involved in homeodomain-DNA binding interactions, it is speculated to provide the right hydrophobic environment for such binding.11 Thus as a result of this P353L mutation we might speculate altered homeodomain-DNA binding capacity of the mutated ARX protein with subsequent deregulation of genes normally under control of this transcription factor. The identity of the genes under control of the ARX protein is not yet known.
Discussion.
We describe a new X-linked recessive syndrome characterized by myoclonic epilepsy, generalized spasticity, and severe intellectual disability (XMESID). The underlying molecular defect in this family has only recently been revealed as a point mutation in the ARX homeobox gene.4 All affected boys had refractory generalized epilepsy, with the predominant seizure types being myoclonic seizures and generalized TCS. A spectrum of severity of intellectual disability could be discerned with one boy with moderate impairment, three boys with severe impairment, and two with profound impairment.
Myoclonic epilepsies in infancy are rare and broadly fit into mild disorders such as benign myoclonic epilepsy of infancy12 and malignant epileptic encephalopathies. XMESID clearly fits into the latter group, which has a limited differential diagnosis.
Myoclonic status in nonprogressive encephalopathies is a heterogeneous condition.13 Angelman syndrome accounts for a significant number of these children and is distinguished by its dysmorphic features and ataxic gait, none of which is seen in XMESID.
Severe myoclonic epilepsy of infancy (SMEI) begins in the first year of life with prolonged hemiclonic or generalized TCS associated with fever. After the first year, partial, absence, and myoclonic seizures may appear. Early development is normal with slowing after the first year, when pyramidal signs and ataxia may develop.14 SMEI does not follow single gene inheritance although it is associated with a family history of epilepsy and febrile seizures.15 Recent studies of patients with SMEI have shown de novo truncation mutations in the gene for the alpha 1 subunit of the sodium channel (SCN1A).16 The family described here differs from SMEI in the temporal pattern of the epileptic encephalopathy, the absence of normal development early in life as well as febrile seizures, and the X-linked inheritance pattern.
Myoclonic epilepsy is also a well-recognized feature of mitochondrial disorders such as MERRF and MELAS. Mitochondrial disorders follow maternal or autosomal recessive inheritance, whereas XMESID follows a classic X-linked recessive pattern. Moreover, mitochondrial disorders are characterized by phenotypic heterogeneity secondary to mitochondrial heteroplasmy. XMESID shows limited heterogeneity, with all affected boys relatively severely affected. Investigations for mitochondrial disorders were negative in the proband and the matriarch.
Progressive impairment is characteristic of the progressive myoclonus epilepsies (PME). Infantile neuronal ceroid lipofuscinosis of Santavuori type is the PME which typically presents in infancy.17,18⇓ It is characterized by a normal early course until 6 to 12 months when regression and ataxia evolve. Myoclonic jerks appear in the second year and progressive microcephaly occurs. These features all differ considerably from XMESID.
The disorder described here most closely resembles ISSX.19 Most reported kindreds have poor outcome with severe intellectual impairment and often early death.9,19,20⇓⇓ In two Belgian families, all eight affected boys had hypsarrhythmia or infantile spasms early in life, and one boy in each family also had myoclonus.20 In a Canadian family, affected boys had normal development until spasm onset between 2 and 4 months, and later myoclonus; but in only one boy was spasticity reported.9 In a Norwegian family, only two of seven boys had infantile spasms (with hypsarrhythmia), and one had TCS; but intellectual outcome was considerably better as five boys had mild intellectual disability (IQ 50 to 70), and only one had profound impairment.8,21⇓ Interestingly some, but not all, affected boys in the Norwegian family had spasticity and ataxia. In all families, carrier women were normal and did not have seizures.
The family reported here is similar to ISSX in terms of the severe outcome for development of affected boys, refractory seizures, and early death in two boys. However, the syndrome also differs in a number of ways. The boys with XMESID had generalized spasticity, a rare feature in ISSX. Carrier women had subtle hyperreflexia and the late onset spastic ataxia of the matriarch may be relevant to the gene defect. The affected boys with XMESID had developmental delay from birth, whereas in some ISSX families, boys have normal early development prior to spasm onset.9 The seizure pattern in all the affected boys with XMESID was quite distinctive, with prominent myoclonic seizures and generalized TCS, both rare accompaniments of infantile spasms (although described in a few cases of ISSX). Only one affected boy with XMESID had infantile spasms with hypsarrhythmia (III-37), and one (proband IV-47) had probable infantile spasms without typical hypsarrhythmia. Thus, in contradistinction to ISSX families where most affected boys have infantile spasms with hypsarrhythmia, classic infantile spasms were rare in XMESID. Differentiation on the basis of infantile spasms may not be valid; hypsarrhythmia may be a transient EEG abnormality and spasms may not always be recognized.
Two Belgian families with ISSX mapped to Xp11.4-Xpter,20 and later work refined the locus to Xp22.1-Xp11.4 to a maximum region of 25cM.8,9⇓ Very recently mutations in ARX4 were found in families with ISSX, syndromic (Partington syndrome, PRTS, MIM 309510) and nonsyndromic intellectual disability. In seven of nine families with ARX defects, expansion mutations of two different polyalanine tracts of the ARX protein were identified, and probably lead to protein aggregation as seen in other polyalanine22 and polyglutamine23 disorders. One other family had a truncation mutation of ARX. The only missense mutation of ARX identified was in the family described here with XMESID, as well as the only mutation confined to the homeodomain. Thus the ARX allelic heterogeneity may explain the phenotypic similarities and differences between XMESID and ISSX. The significant differences at the molecular level produce striking differences in epilepsy phenotypes as well as neurologic manifestations.
An interesting phenomenon in the obligate carrier women described here was their hyperreflexia without other pyramidal features. One hypothesis is that the hyperreflexia represents a marker of carrier status of the gene for this disorder. A corollary exists in the observations of women carriers of the X-linked recessive disorder adrenoleukodystrophy. The most subtle manifestation of neurologic involvement may be hyperreflexia, which does not mean automatic progression to the symptomatic form of adrenomyeloneuropathy.24 The learning difficulties in one obligate carrier (III-34) may also be related to the gene defect responsible for XMESID.
The late adult-onset progressive neurologic disorder in the matriarch II-8 may be unrelated to the disorder in the affected boys in the family. Alternatively, it may be a late manifestation of the gene defect in this family. Late onset neurodegenerative disorders may occur in individuals carrying gene defects on the X chromosome, as recently recognized in normal boys carrying the Fragile X premutation allele.25 Perhaps skewed X inactivation could explain clinical symptoms in the matriarch; however, this was excluded on formal studies. The hypothesis of the progressive spastic ataxia being related to the XMESID gene clearly has major implications for the younger carrier women in the family and their daughters.
To date, almost all genes identified for idiopathic epilepsy syndromes code for ion channels.26 These include voltage gated ion channels, such as sodium channel subunits in generalized epilepsy with febrile seizures plus (GEFS+) and SMEI,16,27-31⇓⇓⇓⇓⇓ and potassium channels in benign familial neonatal convulsions.32,33⇓ Ligand gated ion channels, such as mutations in GABAA receptor subunits, have been identified in childhood absence epilepsy34 and GEFS+,35 and cholinergic receptor defects in autosomal dominant nocturnal frontal lobe epilepsy.36 Recently mutations in the leucine-rich glioma-inactivated 1 gene have been reported in autosomal dominant partial epilepsy with auditory features, a gene important in tumor progression.37
Although the XMESID syndrome is idiopathic in the sense that it has a genetic basis, it does not have the benign outcome associated with many idiopathic epilepsy syndromes. The discovery of the molecular basis of XMESID and ISSX introduces the group of homeobox genes as important players in the neurobiology of severe epileptic encephalopathies. As homeobox genes play a crucial role in development, it is perhaps unsurprising that defects produce such severe epilepsy phenotypes.
Acknowledgments
Supported by research grants from the National Health and Medical Research Council of Australia, the Epilepsy Foundation of Victoria, and the Women’s and Children’s Hospital Research Foundation.
Acknowledgment
The authors thank the family for their participation in the study, Garry Hallas for technical assistance in refining the gene localization, the Australian Genome Research Facility for genotyping, and Professors Gillian Turner and Michael Partington for critical review of the manuscript.
- Received December 4, 2001.
- Accepted April 15, 2002.
References
- ↵
- ↵
- ↵
National Center for Biotechnology Information. Online Mendelian Inheritance in Man (OMIM). #308350 Infantile spasm syndrome, X-linked. Available at: http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?308350.
- ↵
- ↵
- ↵
- ↵
- ↵
Stromme P, Sundet K, Mork C, Cassiman J-J, Fryns J-P, Claes S. X-linked mental retardation and infantile spasms in a new family: new clinical data and linkage to Xp11.4-Xp22.11. J Med Genet . 1999; 36: 374–378.
- ↵
- ↵
- ↵
Wilson DS, Sheng G, Jun S, Desplan C. Conservation and diversification in homeodomain-DNA interactions: a comparative genetic analysis. Proc Natl Acad Sci USA . 1996; 93: 6886–6891.
- ↵
Dravet C, Bureau M, Roger J. Benign myoclonic epilepsy in infants. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence, 2nd ed. London: John Libbey & Company Ltd, 1992: 67–74.
- ↵
Dalla Bernardina B, Fontana E, Sgro V, Colamaria V, Elia M. Myoclonic epilepsy (’myoclonic status’) in non-progressive encephalopathies. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf R, eds. Epileptic Syndromes in Infancy, Childhood and Adolescence, 2nd ed. John Libbey & Company Ltd., 1992:89–96.
- ↵
Dravet C. Les epilepsies graves de l’enfant. La Vie Médicale . 1978; 8: 543–548.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
Restuccia D, Di Lazzaro V, Valeriani M, et al. Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement. Brain . 1997; 120: 1139–1148.
- ↵
Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology . 2001; 57: 127–130.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
Sugawara T, Tsurubuchi Y, Agarwala KL, et al. A missense mutation of the Na+ channel alphaII subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA . 2001; 98: 6384–6389.
- ↵
Biervert C, Schroeder BC, Kubisch C, et al. A potassium channel mutation in neonatal human epilepsy. Science . 1998; 279: 403–406.
- ↵
- ↵
- ↵
- ↵
- ↵
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan
Related Articles
- No related articles found.